CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-09-11 | JORDEN DAVID EMERSON Director | Purchase | +8,333 | $0.95 | $8K | 6,650,000 |
| 2012-08-29 | McLoughlin Mark T Director | Option exercise | +6,667 | 20,001 | ||
| 2012-08-29 | McLoughlin Mark T Director | Option exercise · Warrant | −6,667 | 350,000 | ||
| 2012-08-29 | JORDEN DAVID EMERSON Director | Option exercise | +16,667 | $1.00 | $17K | 6,641,667 |
| 2012-08-29 | JORDEN DAVID EMERSON Director | Option exercise · Warrant | −16,667 | 505,824 | ||
| 2012-08-07 | Maslan Andrew Scott Chief Financial Officer | Option exercise | +10,000 | $1.00 | $10K | 112,780 |
| 2012-08-07 | Maslan Andrew Scott Chief Financial Officer | Option exercise · Warrant | −10,000 | 462,643 | ||
| 2012-08-06 | ROSENDALE MARTIN P Chief Executive Officer | Gift | −8,000 | $1.65 | $13K | 166,918 |
| 2012-08-03 | ROSENDALE MARTIN P Chief Executive Officer | Option exercise | +16,667 | $1.00 | $17K | 174,918 |
| 2012-08-03 | ROSENDALE MARTIN P Chief Executive Officer | Option exercise · Warrant | −16,667 | 1,096,997 | ||
| 2012-07-03 | Maslan Andrew Scott CHIEF FINANCIAL OFFICER | Purchase | +5,000 | $1.08 | $5K | 102,780 |
| 2012-07-03 | ROSENDALE MARTIN P Chief Executive Officer | Purchase | +8,000 | $1.15 | $9K | 158,251 |
| 2012-06-18 | DEL GUERCIO JOSEPH Director | Grant or award · OPTIONS TO PURCHASE SHARES OF COMMON STOCK | +30,000 | 193,998 | ||
| 2012-06-18 | Kent Richard S Director | Grant or award · OPTIONS TO PURCHASE SHARES OF COMMON STOCK | +30,000 | 986,426 | ||
| 2012-06-18 | HOHNKE LYLE A Director | Grant or award · OPTIONS TO PURCHASE SHARES OF COMMON STOCK | +30,000 | 505,000 | ||
| 2012-05-18 | Aldagen Holdings, LLC 10% owner | Conversion | +13,539,816 | 13,539,816 | ||
| 2012-05-18 | Aldagen Holdings, LLC 10% owner | Conversion · Series E Convertible Preferred Stock | −135,398.16 | 0 | ||
| 2012-05-03 | ROSENDALE MARTIN P Chief Executive Officer | Option exercise | +17,922 | $0.54 | $10K | 150,251 |
| 2012-05-03 | ROSENDALE MARTIN P Chief Executive Officer | Option exercise · Warrant | −17,922 | 1,076,259 | ||
| 2012-05-03 | ROSENDALE MARTIN P Chief Executive Officer | Purchase · Warrant | +4,071 | 1,080,330 |
Page 13 of 22 · 436 trades